Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
230.26
-6.19 (-2.62%)
At close: Nov 20, 2026, 4:00 PM EST
230.62
+0.36 (0.16%)
After-hours: Nov 20, 2026, 7:30 PM EST
Jazz Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 205.95 | -356.15 | 560.12 | 414.83 | -224.06 | -329.67 |
Depreciation & Amortization | 718.6 | 696.3 | 660.07 | 638.7 | 629.47 | 552.48 |
Loss (Gain) From Sale of Assets | - | - | - | - | 37.7 | - |
Asset Writedown & Restructuring Costs | 831.16 | 947.86 | 10 | 80.01 | 577.8 | - |
Stock-Based Compensation | 295.83 | 291.13 | 248.05 | 226.84 | 222 | 189.01 |
Provision & Write-off of Bad Debts | 32.11 | 19.11 | 27.76 | 11.11 | 14.54 | 19.67 |
Other Operating Activities | -224.68 | -261.38 | -33.36 | -75.05 | 4.63 | 394.97 |
Change in Accounts Receivable | -110.38 | -106.28 | -21.12 | -51.88 | -90.14 | -92.74 |
Change in Inventory | -115.54 | -86.04 | -45.54 | -13.42 | -49.64 | -48.86 |
Change in Accounts Payable | -20.15 | 39.85 | -20.07 | 9.6 | -11.23 | 57.02 |
Change in Unearned Revenue | - | - | - | - | -2.09 | -2.31 |
Change in Income Taxes | -31.88 | 37.22 | -14.74 | 25.22 | -1.69 | -15.52 |
Change in Other Net Operating Assets | 111.44 | 134.14 | 24.75 | -173.96 | 164.69 | 54.45 |
Operating Cash Flow | 1,692 | 1,356 | 1,396 | 1,092 | 1,272 | 778.51 |
Operating Cash Flow Growth | 21.60% | -2.88% | 27.83% | -14.15% | 63.39% | -13.46% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -70.75 | -58.75 | -38.07 | -23.96 | -29.05 | -27.64 |
Sale of Property, Plant & Equipment | 31.37 | 28.17 | - | - | - | - |
Cash Acquisitions | -830.75 | -858.05 | - | - | - | -6,235 |
Divestitures | - | - | - | - | 53 | - |
Sale (Purchase) of Intangibles | -130.5 | -151 | -10 | -19 | -469.15 | -17.89 |
Investment in Securities | -100.08 | -470.28 | -460.13 | -120.1 | -1.04 | 1,068 |
Investing Cash Flow | -977.91 | -1,510 | -508.2 | -163.06 | -446.23 | -5,212 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 980.77 | - | - | 5,191 |
Total Debt Issued | 1,226 | - | 980.77 | - | - | 5,191 |
Long-Term Debt Repaid | - | -781 | -606 | -31 | -582.01 | -1,321 |
Total Debt Repaid | -1,031 | -781 | -606 | -31 | -582.01 | -1,321 |
Net Debt Issued (Repaid) | 194.9 | -781 | 374.77 | -31 | -582.01 | 3,871 |
Issuance of Common Stock | 151.36 | 107.86 | 20.65 | 46.46 | 98.02 | 135.26 |
Repurchase of Common Stock | -344.94 | -200.24 | -369.18 | -320.71 | -45.5 | -35.6 |
Other Financing Activities | -5.2 | - | -5.72 | - | - | - |
Financing Cash Flow | -3.88 | -873.38 | 20.52 | -305.25 | -529.49 | 3,971 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.35 | 6.56 | -1.68 | 1.14 | -6.22 | -3.21 |
Net Cash Flow | 710.34 | -1,021 | 906.55 | 624.83 | 290.03 | -466.32 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1,622 | 1,297 | 1,358 | 1,068 | 1,243 | 750.87 |
Free Cash Flow Growth | 21.33% | -4.48% | 27.13% | -14.07% | 65.53% | -15.12% |
Free Cash Flow Margin | 34.37% | 30.39% | 33.37% | 27.86% | 33.97% | 24.27% |
Free Cash Flow Per Share | 24.32 | 21.27 | 20.57 | 14.82 | 19.87 | 12.58 |
Levered Free Cash Flow | 1,681 | 1,355 | 1,436 | 1,056 | 1,125 | -138.27 |
Unlevered Free Cash Flow | 1,844 | 1,530 | 1,651 | 1,278 | 1,312 | 37.09 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 248.55 | 248.55 | 314.82 | 333.11 | 270.67 | 138.27 |
Cash Income Tax Paid | 121.81 | 121.81 | 114.91 | 177.88 | 94.68 | 271.22 |
Change in Working Capital | -166.5 | 18.9 | -76.72 | -204.44 | 9.91 | -47.95 |